Tirzepatide vs Ipamorelin
A comprehensive, data-driven comparison of Tirzepatide (Mounjaro) and Ipamorelin (NNC 26-0161). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Tirzepatide Mounjaro, Zepbound | Ipamorelin NNC 26-0161 |
|---|---|---|
| FDA Status | FDA Approved | Category 2 (pending reclassification) |
| Category | Weight Loss | Growth Hormone |
| Primary Use | Type 2 diabetes, chronic weight management, and obstructive sleep apnea | Growth hormone optimization |
| Weight Loss % | 22.5% | N/A |
| Monthly Cost | $1,100 - $1,100/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 15mg weekly (max dose) | 200-300mcg 2-3x daily |
| Frequency | Weekly | Daily |
| Mechanism | Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric emptying, and decreases appetite | Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | High | Emerging |
| Clinical Trial Phase | Approved | N/A |
Key Differences
- 1Tirzepatide is FDA-approved, while Ipamorelin is currently category 2 (pending reclassification).
- 2Tirzepatide has clinical weight loss data (22.5%), while Ipamorelin is not primarily indicated for weight loss.
- 3Ipamorelin is generally more affordable ($35 - $70/mo) compared to Tirzepatide ($1,100 - $1,100/mo).
- 4Tirzepatide is dosed weekly, while Ipamorelin is daily.
- 5Tirzepatide has high-quality evidence, while Ipamorelin has emerging-quality evidence.
- 6They belong to different categories: Tirzepatide (Weight Loss) vs Ipamorelin (Growth Hormone).
Which Is Better For...
Tirzepatide
Those seeking an FDA-approved treatment with established safety data
Ipamorelin
More budget-friendly option with lower monthly costs
Tirzepatide
More convenient dosing schedule (weekly)
Ipamorelin
Fewer commonly reported side effects
Tirzepatide
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Tirzepatide | $1,100 - $1,100/mo | FDA Approved | Eli Lilly |
| Ipamorelin | $35 - $70/mo | Category 2 (pending reclassification) | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Tirzepatide works via Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric. Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. They differ in FDA approval status, efficacy data, and cost.
Tirzepatide has demonstrated 22.5% average weight loss in clinical trials. Ipamorelin is not primarily used for weight loss.
Tirzepatide typically costs $1,100 - $1,100/mo, while Ipamorelin costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Tirzepatide is FDA-approved. Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Tirzepatide include Nausea, Diarrhea, Decreased appetite. Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Tirzepatide is a dual-action peptide approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for weight management. In December 2024, Zepbound became the first and only medication approved fo...
View Full Tirzepatide GuideIpamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...
View Full Ipamorelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tirzepatide and Ipamorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.